SE9703737D0 - Pharmaceutical composition and use - Google Patents

Pharmaceutical composition and use

Info

Publication number
SE9703737D0
SE9703737D0 SE9703737A SE9703737A SE9703737D0 SE 9703737 D0 SE9703737 D0 SE 9703737D0 SE 9703737 A SE9703737 A SE 9703737A SE 9703737 A SE9703737 A SE 9703737A SE 9703737 D0 SE9703737 D0 SE 9703737D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
SE9703737A
Other languages
Swedish (sv)
Inventor
Bengt Axelsson
Ralph Brattsand
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9703737A priority Critical patent/SE9703737D0/en
Publication of SE9703737D0 publication Critical patent/SE9703737D0/en

Links

SE9703737A 1997-10-14 1997-10-14 Pharmaceutical composition and use SE9703737D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE9703737A SE9703737D0 (en) 1997-10-14 1997-10-14 Pharmaceutical composition and use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9703737A SE9703737D0 (en) 1997-10-14 1997-10-14 Pharmaceutical composition and use

Publications (1)

Publication Number Publication Date
SE9703737D0 true SE9703737D0 (en) 1997-10-14

Family

ID=20408603

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9703737A SE9703737D0 (en) 1997-10-14 1997-10-14 Pharmaceutical composition and use

Country Status (1)

Country Link
SE (1) SE9703737D0 (en)

Similar Documents

Publication Publication Date Title
EE200000232A (en) A pharmaceutical composition and its use
ID24654A (en) OMEPRAZOLA PHARMACEUTICAL FORMULATION
DE69618587D1 (en) CHINAZOLINE AND PHARMACEUTICAL COMPOSITIONS
BR9702553A (en) Cosmetic composition and use
BR9500784A (en) Compound and pharmaceutical formulation
BR9504060A (en) Compound and pharmaceutical formulation
ZA985618B (en) Sulfonamide compounds and pharmaceutical use thereof
MA26553A1 (en) ALPHA-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
BR9707501A (en) Compound pharmaceutical composition and use of the compound
NO980546D0 (en) Pharmaceutical agents
LV12624B (en) Thienylazolylalkosietanamines and their application to the drug legusana
BR9707812A (en) Pharmaceutical Compound Compound and Compound Use
BR9707808A (en) Compound pharmaceutical composition and use of the compound
EE9900524A (en) N-Triazolyl-2-indolecarboxamides and their Use as CCK-A Agonists
BR9509688A (en) Pharmaceutical composition and composition
DE59801987D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING PEPTICHEMIO
ID29294A (en) PHARMACEUTICAL COMPOSITION
BR9507768A (en) Pharmaceutical composition
ID25857A (en) PHARMACEUTICAL COMPOSITION
ID18698A (en) PHARMACEUTICAL COMPOSITION
ATE228839T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING TIZOXANIDES AND NITAZOXANIDES
ITMI962628A0 (en) PHARMACEUTICAL COMPOSITION
ID23531A (en) PHARMACEUTICAL COMPOSITION
BR9505130A (en) Pharmaceutical composition and composition
SE9703737D0 (en) Pharmaceutical composition and use